Learn about the role of HPV in cervical cancer
 
What's New

02. September 2014

Roche  launches new fully automated molecular diagnostics systems offering the fastest time to results with the highest testing capacity

The cobas 6800/8800 Systems offer advanced performance with next generation donor screening assays

>more

 

 

22. July 2014 

Roche provides HIV diagnostic update at 2014 International AIDS Conference

Novel solutions contribute towards scale up efforts for HIV diagnosis and monitoring

>more

24. April 2014

FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer 

Expanded indication makes cobasĀ® HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older.

>more


22. July 2014
 

Roche provides HIV diagnostic update at 2014 International AIDS Conference

Novel solutions contribute towards scale up efforts for HIV diagnosis and monitoring.

>more

 Diagnostic and Blood Screening Tests

 

Roche Molecular Diagnostics (RMD) offers a uniquely broad range of diagnostic and blood screening assays based on the company's Nobel prize-winning PCR technologies.

 

RMD's tests and automated platforms are focused in the areas of virology, blood screening, HPV, genomics and oncology, microbiology and sexually transmitted infections. > more

 Contact

Contact your local sales representative for detailed information, questions and ordering.

 

 

 Browse Our Products

 Related Links